Microbacterium Details: NCBI 33882, high G+C gram-positive [genus]

| Aureibacterium| Aureobacterium| Aureobacterium Collins et al. 1983 emend. Yokota et al. 1993| Microbacterium| Microbacterium Orla-Jensen 1919 (Approved Lists 1980) emend. Alves et al. 2014| Microbacterium Orla-Jensen 1919 (Approved Lists 1980) emend. Fidalgo et al. 2016| Microbacterium Orla-Jensen 1919 (Approved Lists 1980) emend. Krishnamurthi et al. 2012| Microbacterium Orla-Jensen 1919 (Approved Lists 1980) emend. Takeuchi and Hatano 1998

  1. Environmental Bacteria:

    • Microbacterium species are primarily environmental bacteria and are commonly found in soil, water, and plant-associated environments.
  2. Plant-Associated Bacteria:

    • Some Microbacterium species have been identified as plant-associated bacteria and may have interactions with plants. In certain cases, they can be beneficial by promoting plant growth or suppressing plant pathogens.
  3. Rare Human Infections:

    • While Microbacterium species are not typically associated with human infections, there have been rare reports of human infections, particularly in individuals with compromised immune systems. In these cases, Microbacterium species have been isolated from clinical specimens.
  4. Opportunistic Pathogens:

    • In immunocompromised individuals, including those with underlying health conditions or undergoing immunosuppressive treatments, certain bacteria that are normally considered environmental or non-pathogenic can become opportunistic pathogens.
  5. Clinical Significance:

    • Infections associated with Microbacterium in humans are infrequent, and the clinical significance of these infections may vary. Reported cases have involved conditions such as bacteremia, skin and soft tissue infections, and prosthetic device-related infections.
  6. Antibiotic Susceptibility:

    • Microbacterium species can exhibit varying antibiotic susceptibilities. Identification of the specific species and testing for antibiotic resistance patterns may be important for appropriate clinical management in the rare instances of human infections.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Microbacterium

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.57 6 400 0 362 100.5 20 133.4 6 400 6.7 %ile 86.7 %ile
biomesight 11.65 0 10 30 0 82 25.5 20 29.1 0 40 0 %ile 92 %ile
thorne 100 13 355 0 215 75.8 56 71.2 6 138 0 %ile 100 %ile
thryve 24.64 0 14 1 1875 0 374 63.3 25 158.7 11 63 0 %ile 100 %ile

External Reference Ranges for Microbacterium

Microbacterium (NCBI 33882) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Thorne (20/80%ile) 13.16 42.75 0.0013 0.0043
Statistic by Lab Source for Microbacterium
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 11.374 %   0.003 %  0.003 % 337.0 2963
BiomeSightRdp 6.452 %   0.002 %  0.001 % 2.0 31
bugspeak 100 %   0.032 %  % 1.0 1
CerbaLab 66.667 %   0.002 %  0 % 2.0 3
custom 1.639 %   0.001 %  % 1.0 61
es-xenogene 13.793 %   0.022 %  0.013 % 4.0 29
Medivere 28.571 %   0.001 %  0 % 2.0 7
Thorne 84.615 %   0.004 %  0.005 % 88.0 104
Thryve 24.82 %   0.006 %  0.015 % 345.0 1390
Tiny 50 %   0.002 %  % 1.0 2

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Diet Style enriched butter diet 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics bacillus amyloliquefaciens (probiotic) 1 Studies recorded. The consensus is Decreases📓, Click for details.

Foods Containing the Microbacterium bacteria

Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.

Cheese with protective lactobacilli in milk Weight: 0.2091 Greek style fermented table olives, Table Olives Kalamata Weight: 0.1829 Curd cheese, cow milk Weight: 0.1653 Cheese Weight: 0.115 Sausage, Cyprus: Paphos Weight: 0.09957 Cheese, Emmental Weight: 0.09183 Ham fermented for 4 years Weight: 0.07024 Pecorino(Italian Cheese) Weight: 0.06716 Cheese, Caciocavallo Weight: 0.05821 Chinese fish sauce Weight: 0.05023 Picual olives Weight: 0.04952 Sausage, Cyprus: Limassol Weight: 0.0451 Fermented finger millet Weight: 0.02075 Cheese with dietary fibers Weight: 0.01838 Sufu - Formented tofu Weight: 0.0108 fermented Hakarl Weight: 0.009224 Dehulled maize dough fermented 12h, Ghana Weight: 0.008384 Ogi from sorghum, Nigeria Weight: 0.008044 Cassava dough, Ghana Weight: 0.0073 Kwerionik, Uganda Weight: 0.007184 Ghee, Uganda Weight: 0.005817 Swiss-Dutch-type cheese Weight: 0.004288 yoghurt fermentation Weight: 0.002973

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.